Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The A-List: 2009's Trend-Shaping Series A Financings

This article was originally published in Start Up

Executive Summary

New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. In biopharmaceuticals, corporate venture got in at the ground floor while device start-ups continued to see stronger support from smaller, regional investors than traditional VCs.
Advertisement

Related Content

Financings Of The Fortnight: More IPOs But More Haircuts As Well
Use Of Protein Biomarkers Punctuates Clovis' Fast-Paced Clinical Trials Strategy
Start-Up Quarterly Statistics, Q4 2009
Following the Money in Medical Devices
Dealmaking in 2009: A Look Back and A Glance Ahead
Alios BioPharma Inc.
The A-List: 2008's Trend Shaping Series A Financings
Will Simpler Devices Tap the Largest Diabetes Market?
Acclarent: Can Balloons Open Sinuses and the ENT Device Market?
The A-List: 2004's Trend-Shaping Series A Financings

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC091886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel